Increased staining for phosphorylated AKT and nuclear factor-κB p65 and their relationship with prognosis in epithelial ovarian cancer
スポンサーリンク
概要
- 論文の詳細を見る
- 2008-12-01
著者
-
Li Liu-xia
Department Of Obstetrics And Gynecology The First Affiliated Hospital Zheng Zhou University
-
Zhou Yan
Department Of Neuroimmunology Research Institute Of Environmental Medicine Nagoya University
-
GUO Rui-Xia
Department of Obstetrics and Gynecology, the First Affiliated Hospital, Zheng Zhou University
-
Zhou Yan
Department Of Obstetrics And Gynecology First Affiliated Hospital Of Zhengzhou University
-
Guo Rui-xia
Department Of Obstetrics And Gynecology First Affiliated Hospital Of Zhengzhou University
-
Shi Hui-rong
Department Of Obstetrics And Gynecology First Affiliated Hospital Of Zhengzhou University
-
Li Liu-xia
Department Of Obstetrics And Gynecology First Affiliated Hospital Of Zhengzhou University
-
QIAO Yu-Huan
Department of Obstetrics and Gynecology, First Affiliated Hospital of Zhengzhou University
-
CHEN Kui-Sheng
Department of Pathology, First Affiliated Hospital of Zhengzhou University
-
Qiao Yu-huan
Department Of Obstetrics And Gynecology First Affiliated Hospital Of Zhengzhou University
-
Chen Kui-sheng
Department Of Pathology First Affiliated Hospital Of Zhengzhou University
-
ZHOU Yan
Department of Electrical and Computer Engineering, National University of Singapore
関連論文
- Blockade of Glutamate Release from Microglia Attenuates Experimental Autoimmune Encephalomyelitis in Mice
- Diabetic ketoacidosis in pregnancy tends to occur at lower blood glucose levels : Case-control study and a case report of euglycemic diabetic ketoacidosis in pregnancy
- A Novel Beam Selection Transmit Diversity Scheme for DS-CDMA System
- Increased staining for phosphorylated AKT and nuclear factor-κB p65 and their relationship with prognosis in epithelial ovarian cancer
- Lanostane-type triterpenes from the sporoderm-broken spores of Ganoderma lucidum
- High FAK combined with low JWA expression : clinical prognostic and predictive role for adjuvant fluorouracil-leucovorin-oxaliplatin treatment in resectable gastric cancer patients